Revolut Users Boosts Injective Growth While INJ Eyes $17.50 Recovery

Revolut users have staked over 200,000 INJ tokens, a major milestone for Injective. It also reflects the growing optimism in its proof-of-stake consensus mechanisms and its adoption in the general market. With its connection with the global fintech platform, users can now easily engage with decentralized finance through the platform’s staking process, without the need for complicated cryptographic infrastructure.

Injective has currently become the largest PoS blockchain onboarding Revolut clients across the globe. The rapid adoption witnessed by the platform enhances security and integrates blockchain technology into the traditional financial system. The more users who lock their INJ, the more Injective places itself as one of the leading scaling solutions for financial use cases.

Also read: Injective Network Adoption Accelerates: Could It Push the INJ Toward $48?

Injective (INJ) Price Reversal Signals Strong Uptrend

However, the crypto analyst, ALTS GEMS Alert, highlighted that Injective spent the month of December under strong selling pressure, yet it garnered very little attention as the token’s price deteriorated. This period of downtrend seems to have created a bottom. Recently, however, market action has affirmed a sector-wide reversal, as buyers dominated the tape, as key resistance levels turned into levels of support, and as overall momentum began trending higher on higher timeframes.

Source: X

Now that the reversal has been validated, it is apparent that the Injective chart is predicting an emerging uptrend. History has shown that it is extremely common to make poor entry points into a trade while chasing green candles. Given that the structure at least appears to be intact, a target of $17.50 has been projected. This highlights the importance of staying patient, getting positioned early, and managing risk carefully during volatile crypto market periods.

Technical Indicators Suggest Improving Momentum

Technically, INJ has been on a downtrend trajectory since October and December of 2025. Generally, this has demonstrated a trend of decreasing highs and lows. Lately, there has been a short-term recovery. The price has managed to go beyond the 20-day SMA of approximately 4.85 and has reached a point close to the 50-day SMA of about 5.21. The levels of the 100-day SMA of approximately 6.84 and the 200-day SMA of approximately 9.99 are somewhat higher.

Source: TradingView

Momentum analysis shows the RSI touching 53.56, which is above 50, indicating weakly bullish markets after the oversold condition. Additionally, the MACD is slightly stronger than the signal line, driven by the positively moving histogram of around 0.1025, although the closeness of the MACD lines shows deceleration. There may be some consolidation or rally, but there would be no breach through the 100-day SMA.

Also Read: Injective Holds Support at $4.41: Could INJ Rebound Toward $29?